Headline
The latest stories from AHA Today.
AdventHealth’s Central Florida division is weathering massive financial losses due to the COVID-19 public health emergency, with losses close to $263 million due in part to declines in so-called elective procedures and the need to source personal protective equipment to aid its pandemic response.
U.S. adults were more likely this June than a year ago to report adverse mental health conditions, substance use and suicidal ideation, according to a report released by the Centers for Disease Control and Prevention.
The Food and Drug Administration warned health care providers and consumers that certain hand sanitizers have tested positive for 1-propanol, including products made by Harmonic Nature S de RL de MI in Mexico.
The Cybersecurity and Infrastructure Security Agency is tracking an unknown malicious cyber actor who is spoofing the Small Business Administration COVID-19 loan relief webpage via phishing emails, the agency announced.
The Department of Health and Human Services today said it will invest $6.5 million in two laboratories, Aegis Sciences Corporation and Sonic Healthcare USA, to add capacity for up to 4 million additional SARS-CoV-2 tests each month.
AHA, along with the American College of Surgeons, American Society of Anesthesiologists and Association of periOperative Registered Nurses, released Joint Statement: Roadmap for Maintaining Essential Surgery During COVID-19 Pandemic, an update to a previous joint statement released in April.
COVID-19 has prompted many changes in the way hospitals manage and care for their patients. As hospitals across the nation deal with the ebb and flow of COVID-19 patients and shortages of intensive-care-unit beds, North Carolina’s Atrium Health has found a promising solution to increasing their…
The Food and Drug Administration released FAQs describing the procedures for importing respirators, face masks, and other personal protective equipment or medical devices for which the agency has issued an emergency use authorization or enforcement discretion policy during the COVID-19 pandemic.
The departments of Health and Human Services and Defense will pay Moderna Inc. about $1.5 billion to produce and deliver 100 million doses of its COVID-19 vaccine candidate to vaccinate Americans if authorized by the Food and Drug Administration, the agencies announced.
The Department of Health and Human Services announced it has expanded the providers eligible for its Public Health and Social Services Emergency Fund “General Distribution.”